Patent details

Basic Information

Publication number:

EP2441449

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP111855078

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Modulation of apolipoprotein C-III expression

French Title of Invention:

Modulation de l'expression de l'apolipoprotéine C-III

German Title of Invention:

Modulation der Apolipoprotein-C-III-Expression

SPC Number:

Dates

Filing date:

15/04/2004

Grant date:

14/10/2015

EP Publication Date:

14/10/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/04/2012

EP B1 Publication Date:

14/10/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/04/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/01/2016

 

 

Name:

Ionis Pharmaceuticals Inc.

Address:

2855 Gazelle Court, Carlsbad, CA 92010, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/10/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Graham Mark J.

Address:

United States (US)

2

Name:

Lemonidis Tarbet Kristina M.

Address:

United States (US)

3

Name:

Crooke Rosanne M.

Address:

United States (US)

4

Name:

Dobie Kenneth

Address:

United States (US)

Priority

Priority Number:

418780

Priority Date:

16/04/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

14/04/2023

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages